Carson Wealth (CWM LLC)’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,214
| Closed | -$668K | – | 5277 |
|
|
2025
Q2 | $668K | Sell |
5,214
-107
| -2% | -$11.1K | ﹤0.01% | 1460 |
|
|
2025
Q1 | $471K | Buy |
5,321
+2,042
| +62% | +$199K | ﹤0.01% | 1468 |
|
|
2024
Q4 | $286K | Buy |
3,279
+1,409
| +75% | +$129K | ﹤0.01% | 1621 |
|
|
2024
Q3 | $173K | Buy |
1,870
+765
| +69% | +$76K | ﹤0.01% | 1833 |
|
|
2024
Q2 | $119K | Buy |
1,105
+590
| +115% | +$59.1K | ﹤0.01% | 1861 |
|
|
2024
Q1 | $49K | Buy |
515
+64
| +14% | +$5.49K | ﹤0.01% | 2306 |
|
|
2023
Q4 | $42K | Sell |
451
-80
| -15% | -$5.18K | ﹤0.01% | 2288 |
|
|
2023
Q3 | $27K | Buy |
531
+115
| +28% | +$6.14K | ﹤0.01% | 2474 |
|
|
2023
Q2 | $26K | Sell |
416
-10
| -2% | -$544 | ﹤0.01% | 2446 |
|
|
2023
Q1 | $19K | Sell |
426
-153
| -26% | -$6.89K | ﹤0.01% | 2536 |
|
|
2022
Q4 | $25K | Buy |
579
+214
| +59% | +$10.3K | ﹤0.01% | 2192 |
|
|
2022
Q3 | $24K | Buy |
365
+42
| +13% | +$2.7K | ﹤0.01% | 2107 |
|
|
2022
Q2 | $16K | Sell |
323
-11
| -3% | -$644 | ﹤0.01% | 2250 |
|
|
2022
Q1 | $21K | Buy |
334
+14
| +4% | +$1K | ﹤0.01% | 2042 |
|
|
2021
Q4 | $34K | Buy |
+320
| New | +$33.5K | ﹤0.01% | 1734 |
|
|
2021
Q2 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2021
Q1 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2020
Q4 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2020
Q3 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2020
Q2 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2020
Q1 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2019
Q4 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2019
Q3 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2019
Q2 | $28K | Hold |
316
| – | – | ﹤0.01% | 1636 |
|
|
2019
Q1 | $28K | Buy |
+316
| New | +$23.4K | ﹤0.01% | 1636 |
|
Other funds holding BPMC
IA
HNB
Carson Wealth (CWM LLC)'s BPMC Position: Q3 2025 in Review
Carson Wealth (CWM LLC) sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 5,214 shares — an estimated $668K sold.
Carson Wealth (CWM LLC) first reported a position in BPMC in Q1 2019 and held it in 25 quarters. The position peaked at $668K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Carson Wealth (CWM LLC) reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Carson Wealth (CWM LLC) sold 5,214 Blueprint Medicines shares in Q3 2025, an estimated $668K.
- Carson Wealth (CWM LLC) first reported a position in Blueprint Medicines in Q1 2019 and held it in 25 quarters.
- Carson Wealth (CWM LLC)'s Blueprint Medicines position peaked at $668K in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2025, filed 15 Oct 2025.